Why the study?
Does citalopram reduce hostility and aggression in individuals scoring high on hostility without major Axis I psychopathology?
Does citalopram reduce hostility and aggression in individuals scoring high on hostility without major Axis I psychopathology?
Citalopram significantly reduces state anger and hostile affect in individuals with high hostility, which may have implications for mitigating psychosocial risk factors for cardiovascular disease.
No takes yet. Share an insight, caveat, or question.
Supports adjunctive citalopram for hostility reduction in CV risk management; extends RCT evidence to non-Axis I populations.
Kamarck et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: